Clinical Trials Directory

Trials / Completed

CompletedNCT01048541

Bladder Scan of Residual Urine With New Catheter

A Non-Inferiority Bladder Scan Study to Investigate Residual Urine After Use of Intermittent Catheters in Male Subjects

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Coloplast A/S · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Male intermittent catheters (ICs) range from 340-500 mm long, with the European standard minimum length being 360 mm for a catheter without a balloon and 275 mm for one with a balloon. This length is defined by hospital standards although it is known that the male urethra has an approximate maximum length of 29 cmA new intermittent catheter developed by Coloplast A/S is a 30-cm-long sterile, ready-to-use, hydrophilic-coated male catheter. There is a lack of clinical data documenting that male ICs that are shorter and more or less flexible than standard catheters can sufficiently empty the bladder of male subjects. This will be tested using ultrasound to measure residual urine in the bladder following catheterisation with new product and standard length catheter.

Detailed description

See brief summary

Conditions

Interventions

TypeNameDescription
DEVICETest Catheter - SpeediCath Compact MaleCompact catheter for intermittent catheterisation
DEVICESpeediCathCatheter for intermittent catheterisation

Timeline

Start date
2010-01-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2010-01-13
Last updated
2012-09-03
Results posted
2012-09-03

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01048541. Inclusion in this directory is not an endorsement.